147 related articles for article (PubMed ID: 19521318)
1. New investigational drugs for lymphoma.
Younes A
Clin Adv Hematol Oncol; 2009 May; 7(5):308-10. PubMed ID: 19521318
[No Abstract] [Full Text] [Related]
2. Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas.
Watanabe T
Expert Opin Investig Drugs; 2010 Sep; 19(9):1113-27. PubMed ID: 20649502
[TBL] [Abstract][Full Text] [Related]
3. [New treatments of malignant lymphoma--a review].
Mark M; Cerny T
Ther Umsch; 2010 Oct; 67(10):537-43. PubMed ID: 20886460
[TBL] [Abstract][Full Text] [Related]
4. New drugs and targeted treatments in Hodgkin's lymphoma.
Provencio M; Sánchez A; Sánchez-Beato M
Cancer Treat Rev; 2014 Apr; 40(3):457-64. PubMed ID: 24095205
[TBL] [Abstract][Full Text] [Related]
5. New anticancer agents.
Weiss GR; Burris 3rd HA; Eckardt JR; Eckhardt SG; Fields SM; O'Rourke T; Rodriguez GI; Rothenberg ML; Valley AJ
Cancer Chemother Biol Response Modif; 1996; 16():132-67. PubMed ID: 8639381
[No Abstract] [Full Text] [Related]
6. Investigational histone deacetylase inhibitors for treating pancreatic adenocarcinoma.
Arlt A; Schäfer H
Expert Opin Investig Drugs; 2016 Nov; 25(11):1251-1254. PubMed ID: 27666721
[No Abstract] [Full Text] [Related]
7. New sources and new antitumor drugs in development.
Weiss RB
Semin Oncol; 1997 Apr; 24(2):153-5. PubMed ID: 9129685
[No Abstract] [Full Text] [Related]
8. [Can new therapy concepts in oncology still be realized? Earlier death with standard therapy].
Pickl S
MMW Fortschr Med; 2002 Dec; 144(49):14. PubMed ID: 12577732
[No Abstract] [Full Text] [Related]
9. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
Kneller S
IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
[No Abstract] [Full Text] [Related]
10. Clinical trial transparency: registries, databases raise questions, stir debate.
Benowitz S
J Natl Cancer Inst; 2005 Nov; 97(22):1640-1. PubMed ID: 16288115
[No Abstract] [Full Text] [Related]
11. Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
Cheson BD
Curr Opin Hematol; 2009 Jul; 16(4):299-305. PubMed ID: 19367159
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies under investigation for mantle cell lymphoma.
Robak T
Expert Opin Investig Drugs; 2016; 25(4):375-80. PubMed ID: 26854527
[No Abstract] [Full Text] [Related]
13. [Individual therapeutic experiments. Ethical problems exemplified in oncology].
Rippe KP
Internist (Berl); 1999 Nov; 40(11):1243-6. PubMed ID: 10636722
[No Abstract] [Full Text] [Related]
14. From the analyst's couch: Next-generation antibodies.
Evans JB; Syed BA
Nat Rev Drug Discov; 2014 Jun; 13(6):413-4. PubMed ID: 24722461
[No Abstract] [Full Text] [Related]
15. [Off-label use in oncology. The Italian choice].
Felicetti V; Gremigni U; Cifaldi L
Recenti Prog Med; 2008 Dec; 99(12):612-5. PubMed ID: 19388222
[TBL] [Abstract][Full Text] [Related]
16. Teaching old drugs new tricks raises hopes of new treatment for lung cancer.
Maurice J
Lancet Respir Med; 2013 Nov; 1(9):677. PubMed ID: 24429265
[No Abstract] [Full Text] [Related]
17. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions.
Croasdell G; Gale S
IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891
[No Abstract] [Full Text] [Related]
18. Clinical trials in adult AML.
Stock W
Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
[No Abstract] [Full Text] [Related]
19. New drug shows promise for advanced colorectal cancer.
Mayo Clin Health Lett; 2012 Jul; 30(7):4. PubMed ID: 22852160
[No Abstract] [Full Text] [Related]
20. Incorporating novel treatment strategies into conventional therapy.
Estey EH
Clin Adv Hematol Oncol; 2009 Jun; 7(6):4-7. PubMed ID: 19645129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
